Citi analyst Joanne Wuensch downgraded the rating on Integer Holdings to a Hold today, setting a price target of $77.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Joanne Wuensch’s rating is based on a combination of factors impacting Integer Holdings. Despite a strong performance in the third quarter of 2025, where revenue and earnings per share exceeded expectations, the company lowered its revenue guidance for 2025 and introduced a 2026 outlook that fell short of market consensus. This adjustment was primarily due to the exit from the Portable Medical segment and unexpected declines in specific electrophysiology and cardiac rhythm management products, which collectively posed a significant revenue headwind.
Management’s anticipation of a recovery in the second half of 2026, coupled with stable backlog and a continued acquisition strategy, suggests potential for future growth. However, the immediate challenges and lowered guidance have led to a more cautious outlook, resulting in the Hold rating. The company’s diversification and emerging market opportunities remain strengths, but the current uncertainties necessitate a wait-and-see approach for investors.
According to TipRanks, Wuensch is a 4-star analyst with an average return of 5.3% and a 58.39% success rate. Wuensch covers the Healthcare sector, focusing on stocks such as Medtronic, Johnson & Johnson, and Tandem Diabetes Care.
In another report released on October 17, TR | OpenAI – 4o also downgraded the stock to a Hold with a $113.00 price target.